A review of several myopathy related to mitochondrial dysfunction
DOI:
https://doi.org/10.29038/NCBio.21.2.45-54Ключові слова:
Citespace, alcoholic myopathy, statins and steroid, mitochondrial dysfunctionАнотація
The balance of protein production and consumption in muscles depends to a large extent on normal mitochondrial function. Mitochondrial dysfunction is inseparable from the occurrence of myopathy. This study explores the relationships between statin-induced myopathy, steroid myopathy, and skeletal muscle illness caused by alcohol addiction, as well as the relationship between these conditions and mitochondrial abnormalities.
Web of Science (WOS) central archive was analyzed for alcoholic myopathy research papers from 1999 to 2021, CiteSpace and WOS databases were used for evaluation the number of written articles, distribution of publications by region, research organizations, co-cited lit-erature analysis, and keyword identification.
A total of 1,255 publications were collected after screening, with the number of published articles continually increasing. The annual average number of publications is 54.56. Six countries publish the majority of the literature. The United States has published 383 papers in total, which places it first among all countries. It also has the most centrality, meaning that other countries value its scientific achievements more. There are 34 core authors and 238 papers published. Through cluster analysis, there are 9 categories that are significant clusters. Key words of co-occurrence research show that keywords such as nanoparticles, apoptosis, mitochondrial disorders, and inflammation are very common.
Посилання
1. Kim, K., Anderson, E. M., Scali, S. T. & Ryan, T. E. Skeletal Muscle Mitochondrial Dysfunction and Oxidative Stress in Peripheral Arterial Disease: A Unifying Mechanism and Therapeutic Target. Antioxidants 9, 2020; p. 1304.
2. Tarnopolsky, M. A. & Raha, S. Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options. Med-icine and science in sports and exercise 37, 2005; pp. 2086–2093.
3. Sahebkar, A. et al. Pathophysiological mechanisms of statin-associated myopathies: possible role of the ubiquitin-proteasome system. Journal of Cachexia, Sarcopenia and Muscle 11, 2020; pp. 1177–1186.
4. Zhang, X. et al. Involvement of reductive stress in the cardiomyopathy in transgenic mice with cardiac-specific overexpression of heat shock protein 27. Hypertension 55, 2010; pp. 1412–1417.
5. Endo, I. et al. Deletion of Vitamin D Receptor Gene in Mice Results in Abnormal Skeletal Muscle Development with Deregulated Expression of Myoregulatory Transcription Factors. Endocrinology 144, 2003; pp. 5138–5144; 10.1210/en.2003-0502 .
6. Couillard, A. Maltais F, Saey D, Debigaré R, Michaud A, Koechlin C, LeBlanc P, Préfaut C. Exercise-induced quadri-ceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstrucyive pulmonary disease. Am J Respir Crit Care Med 167, 2003; pp. 1664–1669.
7. Thompson, P. D., Clarkson, P. & Karas, R. H. Statin-associated myopathy. Jama 289, 2003; pp. 1681–1690.
8. Fernandez-Sola, J. et al. Patients with chronic glucocorti-coid treatment develop changes in muscle glycogen me-tabolism. Journal of the neurological sciences 117, 1993; pp. 103–106.
9. Liu, J. et al. Mitochondrial Dysfunction Launches Dexame-thasone-Induced Skeletal Muscle Atrophy via AMPK/FOXO3 Signaling. Molecular Pharmaceutics 13, 2016; pp. 73–84; 10.1021/acs.molpharmaceut.5b00516.
10. Chen, C. CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature. Journal of the American Society for information Science and Tech-nology 57, 2006; pp. 359–377.
11. Chen, C., Hu, Z., Liu, S. & Tseng, H. Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace. Expert opinion on biological therapy 12, 2012; pp. 593–608.
12. Ochala, J. & Sun, Y.-B. Novel myosin-based therapies for congenital cardiac and skeletal myopathies. Journal of Med-ical Genetics 53, 2016; pp. 651–654; 10.1136/jmedgenet-2016-103881.
13. Salem, R. O., Laposata, M., Rajendram, R., Cluette-Brown, J. E. & Preedy, V. R. THE TOTAL BODY MASS OF FATTY ACID ETHYL ESTERS IN SKELETAL MUSCLES FOL-LOWING ETHANOL EXPOSURE GREATLY EXCEEDS THAT FOUND IN THE LIVER AND THE HEART. Alcohol and Alcoholism 41, 2006; pp. 598–603; 10.1093/alcalc/agl069.
14. Adachi, J. et al. 7alpha- and 7beta-Hydroperoxycholest-5-en-3beta-ol in Muscle as Indices of Oxidative Stress: Re-sponse to Ethanol Dosage in Rats. Alcoholism: Clinical and Experimental Research 24, 2000; pp. 675–681; 10.1111/j.1530-0277. 2000.tb02039.x.
15. Lang, C. H., Frost, R. A., Svanberg, E. & Vary, T. C. IGF-I/IGFBP-3 ameliorates alterations in protein synthesis, eIF4E availability, and myostatin in alcohol-fed rats. American Journal of Physiology-Endocrinology and Metabolism 286, 2004; pp. E916‐E926; 10.1152/ajpendo.00554.2003.
16. Fernandez-Sola, J. et al. Muscle Antioxidant Status in Chronic Alcoholism. Alcoholism: Clinical and Experimental Research 26, 2002; pp. 1858–1862; 10.1111/j.1530-0277.2002.tb02493.x.
17. Nowak, K. J., Ravenscroft, G. & Laing, N. G. Skeletal muscle α-actin diseases (actinopathies): pathology and mechanisms. Acta Neuropathologica 125, 2013; pp. 19–32; 10.1007/s00401-012-1019-z.
18. Gomes, M. J. et al. Beneficial Effects of Physical Exercise on Functional Capacity and Skeletal Muscle Oxidative Stress in Rats with Aortic Stenosis-Induced Heart Failure. Oxida-tive Medicine and Cellular Longevity 2016, pp. 1–12; 10.1155/2016/ 8695716.
19. Preedy, V. R. et al. Alcoholic skeletal muscle myopathy: defi¬ni¬tions, features, contribution of neuropathy, impact and diagnosis. European Journal of Neurology 8, 2001; pp. 677–687; 10.1046/j.1468-1331.2001.00303.x.
20. Laufs, U. et al. Treatment Options for Statin-Associated Muscle Symptoms. Deutsches Aerzteblatt Online, 2015; 10.3238/ arztebl.2015.0748.
21. Gomes, M. J. et al. Skeletal muscle aging: influence of oxidative stress and physical exercise. Oncotarget 8, 2017; pp. 20428–20440; 10.18632/oncotarget.14670.
22. Gavazzi, A., Maria, R. de, Parolini, M. & Porcu, M. Alcohol abuse and dilated cardiomyopathy in men. The American Journal of Cardiology 85, 2000; pp. 1114–1118; 10.1016/S0002-9149(00)00706-2.
23. Glerup, H. et al. Hypovitaminosis D Myopathy Without Bio¬che¬mical Signs of Osteomalacic Bone Involvement. Calcified Tissue International 66, 2000; pp. 419–424; 10.1007/s002230010085.
24. Moßhammer, D., Schaeffeler, E., Schwab, M. & Mörike, K. Mechanisms and assessment of statin-related muscular ad-verse effects: Statin-related myopathy. British Journal of Clinical Pharmacology 78, 2014; pp. 454–466; 10.1111/bcp.12360.
25. Oshima, Y., Kuroda, Y., Kunishige, M., Matsumoto, T. & Mitsui, T. Oxidative stress-associated mitochondrial dys-function in corticosteroid-treated muscle cells. Muscle & Nerve 30, 2004; pp. 49–54; 10.1002/mus.20036.
26. Wajner, M. & Amaral, A. U. Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and an-imal studies. Bioscience Reports 36, 2016; p. e00281; 10.1042/ BSR20150240.
27. 水溶性富勒烯纳米粒子抗氧化活性研究及其肿瘤靶向给药系统的构建. 硕士. 宜春学院. [Zhou, X. Studies on anti-oxidant actactivity of water-soluble fullerene nanoparticles and their construction as tumor targeting drug Studies on antioxidant activity of water-soluble fullerene nanoparticles and their construction as tumor targeting drug, 2020] [in Chinese].
28. Jia, L., Hao, S.-L. & Yang, W.-X. Nanoparticles induce auto¬phagy via mTOR pathway inhibition and reactive oxygen species generation. Nanomedicine 15, 2020; pp. 1419–1435; 10.2217/nnm-2019-0387.
29. Afeseh Ngwa, H. et al. Manganese nanoparticle activates mitochondrial dependent apoptotic signaling and autophagy in dopaminergic neuronal cells. Toxicology and Applied Pharmacology 256, 2011; pp. 227–240; 10.1016/j.taap.2011.07.018.
30. Manzo-Avalos, S. & Saavedra-Molina, A. Cellular and mito-chondrial effects of alcohol consumption. International journal of environmental research and public health 7, 2010; pp. 4281–4304.
31. Bouitbir, J., Sanvee, G. M., Panajatovic, M. V., Singh, F. & Krähenbühl, S. Mechanisms of statin-associated skeletal muscle-associated symptoms. Pharmacological research 154, 2010; 104201.
2. Tarnopolsky, M. A. & Raha, S. Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options. Med-icine and science in sports and exercise 37, 2005; pp. 2086–2093.
3. Sahebkar, A. et al. Pathophysiological mechanisms of statin-associated myopathies: possible role of the ubiquitin-proteasome system. Journal of Cachexia, Sarcopenia and Muscle 11, 2020; pp. 1177–1186.
4. Zhang, X. et al. Involvement of reductive stress in the cardiomyopathy in transgenic mice with cardiac-specific overexpression of heat shock protein 27. Hypertension 55, 2010; pp. 1412–1417.
5. Endo, I. et al. Deletion of Vitamin D Receptor Gene in Mice Results in Abnormal Skeletal Muscle Development with Deregulated Expression of Myoregulatory Transcription Factors. Endocrinology 144, 2003; pp. 5138–5144; 10.1210/en.2003-0502 .
6. Couillard, A. Maltais F, Saey D, Debigaré R, Michaud A, Koechlin C, LeBlanc P, Préfaut C. Exercise-induced quadri-ceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstrucyive pulmonary disease. Am J Respir Crit Care Med 167, 2003; pp. 1664–1669.
7. Thompson, P. D., Clarkson, P. & Karas, R. H. Statin-associated myopathy. Jama 289, 2003; pp. 1681–1690.
8. Fernandez-Sola, J. et al. Patients with chronic glucocorti-coid treatment develop changes in muscle glycogen me-tabolism. Journal of the neurological sciences 117, 1993; pp. 103–106.
9. Liu, J. et al. Mitochondrial Dysfunction Launches Dexame-thasone-Induced Skeletal Muscle Atrophy via AMPK/FOXO3 Signaling. Molecular Pharmaceutics 13, 2016; pp. 73–84; 10.1021/acs.molpharmaceut.5b00516.
10. Chen, C. CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature. Journal of the American Society for information Science and Tech-nology 57, 2006; pp. 359–377.
11. Chen, C., Hu, Z., Liu, S. & Tseng, H. Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace. Expert opinion on biological therapy 12, 2012; pp. 593–608.
12. Ochala, J. & Sun, Y.-B. Novel myosin-based therapies for congenital cardiac and skeletal myopathies. Journal of Med-ical Genetics 53, 2016; pp. 651–654; 10.1136/jmedgenet-2016-103881.
13. Salem, R. O., Laposata, M., Rajendram, R., Cluette-Brown, J. E. & Preedy, V. R. THE TOTAL BODY MASS OF FATTY ACID ETHYL ESTERS IN SKELETAL MUSCLES FOL-LOWING ETHANOL EXPOSURE GREATLY EXCEEDS THAT FOUND IN THE LIVER AND THE HEART. Alcohol and Alcoholism 41, 2006; pp. 598–603; 10.1093/alcalc/agl069.
14. Adachi, J. et al. 7alpha- and 7beta-Hydroperoxycholest-5-en-3beta-ol in Muscle as Indices of Oxidative Stress: Re-sponse to Ethanol Dosage in Rats. Alcoholism: Clinical and Experimental Research 24, 2000; pp. 675–681; 10.1111/j.1530-0277. 2000.tb02039.x.
15. Lang, C. H., Frost, R. A., Svanberg, E. & Vary, T. C. IGF-I/IGFBP-3 ameliorates alterations in protein synthesis, eIF4E availability, and myostatin in alcohol-fed rats. American Journal of Physiology-Endocrinology and Metabolism 286, 2004; pp. E916‐E926; 10.1152/ajpendo.00554.2003.
16. Fernandez-Sola, J. et al. Muscle Antioxidant Status in Chronic Alcoholism. Alcoholism: Clinical and Experimental Research 26, 2002; pp. 1858–1862; 10.1111/j.1530-0277.2002.tb02493.x.
17. Nowak, K. J., Ravenscroft, G. & Laing, N. G. Skeletal muscle α-actin diseases (actinopathies): pathology and mechanisms. Acta Neuropathologica 125, 2013; pp. 19–32; 10.1007/s00401-012-1019-z.
18. Gomes, M. J. et al. Beneficial Effects of Physical Exercise on Functional Capacity and Skeletal Muscle Oxidative Stress in Rats with Aortic Stenosis-Induced Heart Failure. Oxida-tive Medicine and Cellular Longevity 2016, pp. 1–12; 10.1155/2016/ 8695716.
19. Preedy, V. R. et al. Alcoholic skeletal muscle myopathy: defi¬ni¬tions, features, contribution of neuropathy, impact and diagnosis. European Journal of Neurology 8, 2001; pp. 677–687; 10.1046/j.1468-1331.2001.00303.x.
20. Laufs, U. et al. Treatment Options for Statin-Associated Muscle Symptoms. Deutsches Aerzteblatt Online, 2015; 10.3238/ arztebl.2015.0748.
21. Gomes, M. J. et al. Skeletal muscle aging: influence of oxidative stress and physical exercise. Oncotarget 8, 2017; pp. 20428–20440; 10.18632/oncotarget.14670.
22. Gavazzi, A., Maria, R. de, Parolini, M. & Porcu, M. Alcohol abuse and dilated cardiomyopathy in men. The American Journal of Cardiology 85, 2000; pp. 1114–1118; 10.1016/S0002-9149(00)00706-2.
23. Glerup, H. et al. Hypovitaminosis D Myopathy Without Bio¬che¬mical Signs of Osteomalacic Bone Involvement. Calcified Tissue International 66, 2000; pp. 419–424; 10.1007/s002230010085.
24. Moßhammer, D., Schaeffeler, E., Schwab, M. & Mörike, K. Mechanisms and assessment of statin-related muscular ad-verse effects: Statin-related myopathy. British Journal of Clinical Pharmacology 78, 2014; pp. 454–466; 10.1111/bcp.12360.
25. Oshima, Y., Kuroda, Y., Kunishige, M., Matsumoto, T. & Mitsui, T. Oxidative stress-associated mitochondrial dys-function in corticosteroid-treated muscle cells. Muscle & Nerve 30, 2004; pp. 49–54; 10.1002/mus.20036.
26. Wajner, M. & Amaral, A. U. Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and an-imal studies. Bioscience Reports 36, 2016; p. e00281; 10.1042/ BSR20150240.
27. 水溶性富勒烯纳米粒子抗氧化活性研究及其肿瘤靶向给药系统的构建. 硕士. 宜春学院. [Zhou, X. Studies on anti-oxidant actactivity of water-soluble fullerene nanoparticles and their construction as tumor targeting drug Studies on antioxidant activity of water-soluble fullerene nanoparticles and their construction as tumor targeting drug, 2020] [in Chinese].
28. Jia, L., Hao, S.-L. & Yang, W.-X. Nanoparticles induce auto¬phagy via mTOR pathway inhibition and reactive oxygen species generation. Nanomedicine 15, 2020; pp. 1419–1435; 10.2217/nnm-2019-0387.
29. Afeseh Ngwa, H. et al. Manganese nanoparticle activates mitochondrial dependent apoptotic signaling and autophagy in dopaminergic neuronal cells. Toxicology and Applied Pharmacology 256, 2011; pp. 227–240; 10.1016/j.taap.2011.07.018.
30. Manzo-Avalos, S. & Saavedra-Molina, A. Cellular and mito-chondrial effects of alcohol consumption. International journal of environmental research and public health 7, 2010; pp. 4281–4304.
31. Bouitbir, J., Sanvee, G. M., Panajatovic, M. V., Singh, F. & Krähenbühl, S. Mechanisms of statin-associated skeletal muscle-associated symptoms. Pharmacological research 154, 2010; 104201.
Завантаження
Опубліковано
2022-02-03
Номер
Розділ
Фізіологія людини і тварин
Як цитувати
A review of several myopathy related to mitochondrial dysfunction. (2022). Нотатки сучасної біології, 2(2), 45-54. https://doi.org/10.29038/NCBio.21.2.45-54
